| 18 Mar 2010 |
|
SKMC Organizes the Pathology and Laboratory Medicine Update Conference on 20 March 2010
- Text size
Under the endorsement of Abu Dhabi Health Services CompanyAbu Dhabi Health Services Company
- SEHASEHA, the Laboratory Medicine Department at Sheikh Khalifa Medical CitySheikh Khalifa Medical City (SKMCSKMC), managed by Cleveland Clinic, organizes a joint conference on Pathology and Laboratory Medicine at the Hilton Hotel - Abu Dhabi on 20 March 2010 with the United Kingdom Accreditation Service (UKAS)/Clinical Pathology Accreditation (CPA) and the Royal College of Pathologists in UK. SKMCSKMC is owned and operated by SEHA, the Abu Dhabi Health Services CompanySEHA, the Abu Dhabi Health Services Company, which is responsible for the curative activities of all the public hospitals and clinics in the Emirate of Abu Dhabi.The conference will be chaired by Dr. Laila Abdel-Wareth, Chair of Laboratory Medicine at SKMCSKMC; and Dr. Robby Bacchus, Coordinator UKAS/CPA, RCPath representative to WASPaLM. A distinguished faculty of experts from the Royal College of Pathologists- UK will present the latest views on various aspects of Laboratory Accreditation, Clinical Chemistry, Microbiology, Hematology and Anatomic pathology. The conference will host up to 200 delegates and targets laboratory medicine professionals and clinicians with an interest in hematology, chemistry, microbiology or dermatology.
The speakers will cover various topics and updates in the field of laboratory medicine including quality, accreditation as well several new developments within the field of hematology, microbiology, clinical chemistry, anatomic pathology, diabetes, bladder carcinoma and vitamin D. The conference, which will start at 09.00 am until 05.00 pm, is accredited for six (6) hours of Continuous Medical Education (CME) by the Health Authority-Abu Dhabi (HAAD).
The conference will start with presentations about laboratory accreditation for clinical pathology, followed by an update on diabetes and cardiac markers. The afternoon session will contain discussions about viral hepatitis and hemostasis testing while the final session will cover topics in anatomic pathology such as lymph node and urinary bladder cancer. Dr Afrozul Haq, Senior Clinical Scientist at the Pathology and Laboratory Medicine Department of SKMCSKMC will speak about Vitamin D, its deficiency and cardiovascular disease.
Dr. Atul Mehta, Chief Medical Officer at SKMCSKMC
, believes that holding this conference enhances SKMCSKMC role as a provider of comprehensive state-of-the-art patient care services, and as an active promoter of continuous medical education (CME). He avowed that "The conference will be an opportunity to exchange scientific and professional experiences by SKMCSKMC physicians, clinicians, technicians and other international institutions with the conference participants." Dr. Laila Abdel-Wareth said: "We look forward for this opportunity to mingle with individuals with similar interests and views about Pathology and Laboratory Medicine. It is a real opportunity to take advantage of networking with colleagues as this is a valuable platform to share experiences, craft solutions and form lasting relationships with international medical centers and organizations."
Dr. Afrozul Haq also stated, "We are proud to welcome the elite group of professionals at this conference to share their successful knowledge and expertise with SKMCSKMC
professionals and the UAE medical community.""SKMCSKMC employs approximately 180 practitioners of clinical laboratory science in the Pathology and Laboratory Medicine department who play an increasingly vital role in the diagnosis and prevention of disease. In 2009, more than 2 million laboratory tests were performed for our in-patients and outpatients in SKMCSKMC's specialty clinics," Dr. Laila Abdel-Wareth added.
-End-
About SKMC
Sheikh Khalifa Medical CitySheikh Khalifa Medical City (SKMCSKMC), located in Abu Dhabi, UAE, operates under the management of Cleveland Clinic, consistently named by U.S. News and World Report as one of the nation's best hospitals in its annual "America's Best Hospitals" survey. SKMCSKMC is owned by SEHA, the Abu Dhabi Health Services CompanySEHA, the Abu Dhabi Health Services Company, recently established to oversee operations of all public hospitals in the Emirate. SKMCSKMC is the flagship institution for the public health system in Abu Dhabi and has several 'Centers of Excellence', and aspires to practice contemporary medicine comparable to the best hospitals and medical centers in the world. SKMCSKMC provides comprehensive healthcare services in all of the disciplines relevant to the needs and priorities of the community to attain the highest levels of patient satisfaction.
consists of a 568-bed Acute Care Hospital, 14 specialized outpatient clinics and the Abu Dhabi Blood Bank accredited by the Joint Commission International (JCI). In addition, SKMCSKMC manages a 125-bed Behavior Sciences Pavilion, an 88-bed Rehabilitation Center, 3 Urgent Care Centers, 6 Family Medicine Clinics and 2 Dental Centers distributed over the city of Abu Dhabi. For further information, send an email to marketing@skmc.gov.ae. About SEHASEHA - Abu Dhabi Health Services Company
SEHASEHA is health in Arabic. The Abu Dhabi Health Services CompanyAbu Dhabi Health Services Company - whose corporate identity is SEHASEHA - is an independent, public joint stock company created to manage and develop the curative activities of the public hospitals and clinics of the Emirate of Abu Dhabi. SEHASEHA is committed to providing quality, cost effective healthcare on par with international standards measured through accessibility, affordability, choice and satisfaction. SEHASEHA owns and operates 12 hospitals, 2,644 licensed beds, 62 Ambulatory, Primary Health and ancillary care clinics and 2 Blood Banks. SEHASEHA employs more than 15,500 doctors, nurses and other clinical staff and administration. For further information, contact James S Ferrier, Corporate Marketing Manager at jferrier@seha.ae or Salama Al Mazrouei, Sr. Corporate Marketing Specialist at smazrouei@seha.ae, or visit our website at www.seha.ae.
For more information please contact:
Farah Al Alami
Senior Officer Media
Tel.: +971506611428
© Press Release 2010
Zawya is a distributor (and not a publisher) of content supplied by third parties and subscribers. Any opinions, advice, statements, services, offers, or other information or content expressed or made available by those third parties, including information providers, subscribers or other users of the Service, are those of the respective author(s) or distributor(s) and not of the Company. The Company neither endorses nor is responsible for the accuracy or reliability of any opinion, advice or statement made on the Service by anyone other than authorized Service employee spokespersons while acting in their official capacities. The Company is not responsible for any infringement of intellectual property rights or breach of any applicable law or regulation, including regulation in relation to financial services or the distribution of financial products, defamation, data protection, telecommunications (including regulations relating to excessive use, spamming or other abusive activities) or obscene, offensive or illegal content). Under no circumstances will the Company be liable for any loss or damage caused by a member's reliance on information obtained through the Service. It is the responsibility of member to evaluate the accuracy, completeness or usefulness of any information, opinion, advice or other content available through the Service. Please seek the advice of professionals, as appropriate, regarding the evaluation of any specific information, opinion, advice or other content.
Read the full Member Agreement
http://www.zawya.com/legal/NewsLetter.cfm?name=disclaimer
Post a Comment
1.1 Contain any material which is libelous or defamatory of any person, is obscene, offensive, hateful or inflammatory or causes damage to the reputation of any person or organisation.
1.2 Promote sexually explicit material, violence, discrimination based on race, sex, religion, nationality, disability, sexual orientation or age or any illegal activity.
1.3 Be made in breach of any legal duty owed to a third party, such as a contractual duty or a duty of confidence.
1.4 Be threatening, abuse or invade another's privacy, or cause annoyance, inconvenience or needless anxiety.
1.5 Be used to impersonate any person, to misrepresent your identity or affiliation with any person, or be likely to deceive any person.
1.6 Give the impression that they represent Zawya.
1.7 Advocate, promote or assist any unlawful act such as (by way of example only) copyright infringement or computer misuse.